Performance of anti-HEV assays for diagnosing acute hepatitis E in immunocompromised patients

Journal of Clinical Virology

Volumn 58, Issue 4, 2013, Pages 624-628

  Abravanel, Florence ^a,b   Chapuy Regaud, Sabine ^a,b   Lhomme, Sébastien ^a,b   Miedougé, Marcel ^b   Peron, Jean Marie ^c   Alric, Laurent ^c   Rostaing, Lionel ^a,b   Kamar, Nassim ^a,b   Izopet, Jacques ^a,b  

^a INSERM   (France)

^b TOULOUSE UNIVERSITY HOSPITAL   (France)

^c CHU PURPAN   (France)

Author keywords

Hepatitis E virus; Immunosuppression; Sensitivity; Serology; Specificity

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN M ANTIBODY;

ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC KIT; EUROPE; HEPATITIS E; HUMAN; IMMUNOASSAY; IMMUNOCOMPROMISED PATIENT; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

HEPATITIS E VIRUS; HEV; IMMUNOSUPPRESSION; INTERNATIONAL UNIT; INTERQUARTILE RANGE; IQR; IU; OPEN READING FRAMES; ORF; SENSITIVITY; SEROLOGY; SPECIFICITY;

HEPATITIS ANTIBODIES; HEPATITIS E; HUMANS; IMMUNOCOMPROMISED HOST; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; SENSITIVITY AND SPECIFICITY; SEROLOGIC TESTS;

EID: 84888845230     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2013.10.003     Document Type: Article

References (37)

1. Hoofnagle J.H., Nelson K.E., Purcell R.H., Hepatitis E. N Engl J Med 2012, 367:1237-1244.
2. Kamar N., Bendall R., Legrand-Abravanel F., Xia N.S., Ijaz S., Izopet J., et al. Hepatitis E. Lancet 2012, 379:2477-2488.
3. Ahmad I., Holla R.P., Jameel S. Molecular virology of hepatitis E virus. Virus Res 2011, 161:47-58.
4. Yarbough P.O., Tam A.W., Fry K.E., Krawczynski K., McCaustland K.A., Bradley D.W., et al. Hepatitis E virus: identification of type-common epitopes. J Virol 1991, 65:5790-5797.
5. Lu L., Li C., Hagedorn C.H. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol 2006, 16:5-36.
6. Gerolami R., Moal V., Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008, 358:859-860.
7. Haagsma E.B., van den Berg A.P., Porte R.J., Benne C.A., Vennema H., Reimerink J.H., et al. Chronic hepatitis E virus infection in liver transplant recipients. Liver Transplant 2008, 14:547-553.
8. Kamar N., Selves J., Mansuy J.M., Ouezzani L., Peron J.M., Guitard J., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med 2008, 358:811-817.
9. Halac U., Beland K., Lapierre P., Patey N., Ward P., Brassard J., et al. Chronic hepatitis E infection in children with liver transplantation. Gut 2012, 61:597-603.
10. Halac U., Beland K., Lapierre P., Patey N., Ward P., Brassard J., et al. Cirrhosis due to chronic hepatitis E infection in a child post-bone marrow transplant. J Pediatr 2012, 160:871-874. e1.
11. Ollier L., Tieulie N., Sanderson F., Heudier P., Giordanengo V., Fuzibet J.G., et al. Chronic hepatitis after hepatitis E virus infection in a patient with non-Hodgkin lymphoma taking rituximab. Ann Intern Med 2009, 150:430-431.
12. Tavitian S., Peron J.M., Huynh A., Mansuy J.M., Ysebaert L., Huguet F., et al. Hepatitis E virus excretion can be prolonged in patients with hematological malignancies. J Clin Virol 2010, 49:141-144.
13. Dalton H.R., Bendall R.P., Keane F.E., Tedder R.S., Ijaz S. Persistent carriage of hepatitis E virus in patients with HIV infection. N Engl J Med 2009, 361:1025-1027.
14. Kenfak-Foguena A., Schoni-Affolter F., Burgisser P., Witteck A., Darling K.E., Kovari H., et al. Hepatitis E Virus seroprevalence and chronic infections in patients with HIV, Switzerland. Emerg Infect Dis 2011, 17:1074-1078.
15. Colson P., Kaba M., Moreau J., Hepatitis Brouqui P. E in an HIV-infected patient. J Clin Virol 2009, 45:269-271.
16. Kamar N., Mansuy J.M., Cointault O., Selves J., Abravanel F., Danjoux M., et al. Hepatitis E virus-related cirrhosis in kidney- and kidney-pancreas-transplant recipients. Am J Transplant 2008, 8:1744-1748.
17. Legrand-Abravanel F., Kamar N., Sandres-Saune K., Lhomme S., Mansuy J.M., Muscari F., et al. Hepatitis E virus infection without reactivation in solid-organ transplant recipients, France. Emerg Infect Dis 2011, 17:30-37.
18. Haagsma E.B., Niesters H.G., van den Berg A.P., Riezebos-Brilman A., Porte R.J., Vennema H., et al. Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transplant 2009, 15:1225-1228.
19. Pischke S., Suneetha P.V., Baechlein C., Barg-Hock H., Heim A., Kamar N., et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transplant 2010, 16:74-82.
20. Kamar N., Legrand-Abravanel F., Izopet J., Rostaing L. Hepatitis E virus: what transplant physicians should know. Am J Transplant 2012, 12:2281-2287.
21. Huang S., Zhang X., Jiang H., Yan Q., Ai X., Wang Y., et al. Profile of acute infectious markers in sporadic hepatitis E. PLoS ONE 2010, 5:e13560.
22. Mast E.E., Alter M.J., Holland P.V., Purcell R.H. Evaluation of assays for antibody to hepatitis E virus by a serum panel Hepatitis E Virus Antibody Serum Panel Evaluation Group. Hepatology 1998, 27:857-861.
23. Drobeniuc J., Meng J., Reuter G., Greene-Montfort T., Khudyakova N., Dimitrova Z., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010, 51:e24-e27.
24. Abravanel F., Sandres-Saune K., Lhomme S., Dubois M., Mansuy J.M., Izopet J. Genotype 3 diversity and quantification of hepatitis e virus RNA. J Clin Microbiol 2012, 50:897-902.
25. Legrand-Abravanel F., Mansuy J.M., Dubois M., Kamar N., Peron J.M., Rostaing L., et al. Hepatitis E virus genotype 3 diversity, France. Emerg Infect Dis 2009, 15:110-114.
26. Legrand-Abravanel F., Thevenet I., Mansuy J.M., Saune K., Vischi F., Peron J.M., et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol 2009, 16:772-774.
27. Khan A., Tanaka Y., Kurbanov F., Elkady A., Abbas Z., Azam Z., et al. Investigating an outbreak of acute viral hepatitis caused by hepatitis E virus variants in Karachi, South Pakistan. J Med Virol 2011, 83:622-629.
28. Bendall R., Ellis V., Ijaz S., Thurairajah P., Dalton H.R. Serological response to hepatitis E virus genotype 3 infection: IgG quantitation, avidity, and IgM response. J Med Virol 2008, 80:95-101.
29. Bendall R., Ellis V., Ijaz S., Ali R., Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol 2010, 82:799-805.
30. Mansuy J.M., Bendall R., Legrand-Abravanel F., Saune K., Miedouge M., Ellis V., et al. Hepatitis E virus antibodies in blood donors, France. Emerg Infect Dis 2011, 17:2309-2312.
31. Abravanel F., Mansuy J.M., Huynh A., Kamar N., Alric L., Peron J.M., et al. Low risk of hepatitis E virus reactivation after haematopoietic stem cell transplantation. J Clin Virol 2012, 54:152-155.
32. Rossi-Tamisier M., Moal V., Gerolami R., Colson P. Discrepancy between anti-hepatitis E virus immunoglobulin G prevalence assessed by two assays in kidney and liver transplant recipients. J Clin Virol 2012, 56:62-64.
33. Wenzel J.J., Preiss J., Schemmerer M., Huber B., Jilg W. Test performance characteristics of anti-HEV IgG assays strongly influence hepatitis E seroprevalence estimates. J Infect Dis 2012, 207:497-500.
34. Zhang J.Z., Ng M.H., Xia N.S., Lau S.H., Che X.Y., Chau T.N., et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol 2001, 64:125-132.
35. Kamar N., Rostaing L., Legrand-Abravanel F., Izopet J. How should hepatitis E virus infection be defined in organ-transplant recipients?. Am J Transplant 2013 July, 13(7):1935-1936.
36. Baylis S.A., Hanschmann K.M., Blumel J., Nubling C.M. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011, 49:1234-1239.
37. Abravanel F., Chapuy-Regaud S., Lhomme S., Dubois M., Peron J.M., Alric L., et al. Performance of two commercial assays for detecting hepatitis E virus RNA in acute or chronic infections. J Clin Microbiol 2013, 51:1913-1916.